Bio-Rad Laboratories, Inc. BIO.B Payments to Acquire Investments
Payments to Acquire Investments at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireInvestments.
The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories, Inc.'s payments to acquire investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories, Inc.'s payments to acquire investments?
- Bio-Rad Laboratories, Inc. (BIO.B) reported payments to acquire investments of $226.1M in Q1 2026.
- How has Bio-Rad Laboratories, Inc.'s payments to acquire investments changed year-over-year?
- Bio-Rad Laboratories, Inc.'s payments to acquire investments increased by 47.4% year-over-year, from $153.4M to $226.1M.
- What is the long-term trend for Bio-Rad Laboratories, Inc.'s payments to acquire investments?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories, Inc.'s payments to acquire investments has grown at a -5.8% compound annual growth rate (CAGR), from $851.63M to $669.3M.